Christine Lind
Amministratore Delegato presso BACTIGUARD HOLDING AB
Patrimonio netto: 19 675 $ in data 30/04/2024
Posizioni attive di Christine Lind
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| XSPRAY PHARMA AB | Direttore/Membro del Consiglio | 01/01/2019 | - |
| Independent Dir/Board Member | 01/01/2019 | - | |
| MENDUS AB | Independent Dir/Board Member | 01/01/2020 | - |
| Presidente | 22/01/2021 | - | |
| Direttore/Membro del Consiglio | 01/01/2020 | 22/01/2021 | |
| BACTIGUARD HOLDING AB | Amministratore Delegato | 12/04/2024 | - |
Lind Growth Strategy AB
 Lind Growth Strategy AB Miscellaneous Commercial ServicesCommercial Services Lind Growth Strategy AB is a private company that provides life science consulting services. The CEO of the Swedish company is Christine Lind. | Presidente | 01/03/2019 | - |
| Amministratore Delegato | - | - | |
| Direttore/Membro del Consiglio | - | - | |
NDA Group AB
 NDA Group AB Miscellaneous Commercial ServicesCommercial Services NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden. | Corporate Officer/Principal | 01/04/2021 | - |
| Shinka Life Sciences AB | Corporate Officer/Principal | - | - |
Storia della carriera di Christine Lind
Precedenti posizioni note di Christine Lind
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MEDIVIR AB | Amministratore Delegato | 01/04/2017 | 15/10/2018 |
| Corporate Officer/Principal | 01/03/2015 | 01/04/2017 | |
| Presidente | - | 15/10/2018 | |
| BIOARCTIC AB | Corporate Officer/Principal | 01/01/2019 | - |
| Medivir Personal AB | Direttore/Membro del Consiglio | - | - |
| ░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di Christine Lind
| Columbia Business School | Masters Business Admin |
| The Leonard N Stern School of Business | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Svezia | 11 |
| Stati Uniti | 4 |
Posizioni
| Corporate Officer/Principal | 5 |
| Director/Board Member | 5 |
| Chief Executive Officer | 3 |
Settori
| Health Technology | 7 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| MEDIVIR AB | Health Technology |
| BIOARCTIC AB | Health Technology |
| XSPRAY PHARMA AB | Health Technology |
| MENDUS AB | Health Technology |
| BACTIGUARD HOLDING AB | Health Technology |
| Aziende private | 6 |
|---|---|
LifeCell Corp.
 LifeCell Corp. BiotechnologyHealth Technology LifeCell Corp. develops and markets tissue repair products. The firm focuses on reconstructive, urogynecologic and orthopedic surgical procedures. Its products include alloderm, strattice, graft jacket, allocraftdbm and repliform. The company was founded in 1986 and is headquartered in Branchburg, NJ. | Health Technology |
NDA Group AB
NDA Group AB Miscellaneous Commercial ServicesCommercial Services NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden. | Commercial Services |
| Medivir Personal AB | |
| Glycovisc BioTech AB | |
Lind Growth Strategy AB
Lind Growth Strategy AB Miscellaneous Commercial ServicesCommercial Services Lind Growth Strategy AB is a private company that provides life science consulting services. The CEO of the Swedish company is Christine Lind. | Commercial Services |
| Shinka Life Sciences AB |
- Borsa valori
- Insiders
- Christine Lind
- Esperienza
